Wealth Management Partners LLC Purchases 6,678 Shares of Astera Labs, Inc. $ALAB

Wealth Management Partners LLC increased its position in Astera Labs, Inc. (NASDAQ:ALAB) by 25.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,755 shares of the company’s stock after buying an additional 6,678 shares during the quarter. Astera Labs accounts for approximately 1.6% of Wealth Management Partners LLC’s investment portfolio, making the stock its 15th largest position. Wealth Management Partners LLC’s holdings in Astera Labs were worth $5,449,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Assetmark Inc. boosted its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares during the period. Hilltop National Bank raised its position in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after acquiring an additional 100 shares during the last quarter. Aventura Private Wealth LLC bought a new position in Astera Labs during the 4th quarter worth approximately $33,000. National Bank of Canada FI lifted its position in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after purchasing an additional 124 shares during the period. Finally, Wexford Capital LP bought a new stake in shares of Astera Labs in the 3rd quarter valued at $39,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

ALAB stock opened at $121.76 on Wednesday. The company’s 50-day moving average is $141.95 and its 200-day moving average is $165.11. The stock has a market capitalization of $20.85 billion, a PE ratio of 99.80, a price-to-earnings-growth ratio of 2.44 and a beta of 1.74. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm’s revenue was up 91.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Company benefits from robust AI infrastructure demand — management/product roadmaps (Scorpio, Aries, Taurus) and hyperscaler spend are cited as growth drivers for 2026, supporting revenue momentum and longer‑term upside. ALAB Benefits From Strong AI Infrastructure Demand: What’s Ahead?
• Positive Sentiment: Index inclusion and a new shelf filing improve the stock’s public market profile — FTSE All‑World inclusion can create passive fund flows, while a shelf gives management optionality to raise capital if needed. Astera Labs Index Entry And Shelf Filing Shape Capital Access Story
• Neutral Sentiment: Management presented at the Roth conference — the transcript provides additional detail on strategy and product roadmap but contains no new market‑moving surprises. Astera Labs, Inc. (ALAB) Presents at The 38th Annual Roth Conference Transcript
• Neutral Sentiment: Market writeups explaining today’s dip summarize mixed technicals/valuation and short‑term profit‑taking rather than a single fundamental shock. Why Astera Labs, Inc. (ALAB) Dipped More Than Broader Market Today
• Negative Sentiment: Short interest has risen materially (reported ~13.5M shares as of Mar. 13, ~9.1% of shares sold short, ~2.8 days to cover) — higher short positioning increases downside pressure and volatility on negative news or further technical selling.
• Negative Sentiment: Analyst/commentary pieces flag a recent pullback and question near‑term valuation after a strong prior run; that bearish tone can reinforce selling among momentum traders. Is It Too Early To Reconsider Astera Labs (ALAB) After Recent Share Price Pullback

Analysts Set New Price Targets

ALAB has been the subject of a number of analyst reports. Northland Securities lifted their target price on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Royal Bank Of Canada started coverage on Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective for the company. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Citigroup decreased their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a report on Wednesday, December 3rd. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $202.22.

Insider Activity at Astera Labs

In other news, Director Jack R. Lazar sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $119.80, for a total transaction of $898,500.00. Following the transaction, the director directly owned 87,351 shares of the company’s stock, valued at $10,464,649.80. This represents a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief operating officer owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. This represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 384,292 shares of company stock valued at $48,724,919 over the last three months. 12.50% of the stock is currently owned by company insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.